Sponsor
Interius Biotherapeutics Inc.
3401 Grays Ferry Avenue Building 200 Office 300, 19146-2701, United States
About the sponsor
Clinical research is centered on refractory and relapsing B-cell malignancies, with a focus on cancers that return after prior treatment.
- B-cell cancers
- Relapsed disease
- Refractory malignancy
The trial activity reflects interest in treatment-resistant hematologic cancer settings and adult populations with limited remaining options.
Try clearing a filter, or search the whole catalogue.
Are you running a clinical trial?
Increase visibility for your trials and help patients find your site through our platform.